EMA warns of rise in illegal weight loss drugs marketed online
The alert is part of a growing trend in the prevalence of counterfeit and unregulated GLP-1RAs.
Therapy Area
Bavarian Nordic’s Vimkunya makes UK debut amid Ixchiq suspension
Novartis adds again to siRNA pipeline with second deal in a day
Health Canada approves AbbVie’s Elahere for ovarian cancer
Novartis returns to alpha-synuclein with $2.2bn Arrowhead deal
Chinese drugmakers prep for looming semaglutide generics horizon
Oxford University and Ellison Institute link for AI vaccine research
China’s NMPA conditionally approves Boehringer’s tablets for NSCLC
